B4 Pharm Exam 1 (Lectures 1-10)
How hyperlipidemia leads to heart failure Correct Answer: hyperlip -- athero -- CHD (ie. angina, MI) and/or HTN -- heart failure Classes of Antihyperlipidemic Drugs Correct Answer: - HMG-CoA reductase inhibs (statins) - Bile acid sequestrants - Chol absorp inhibs - Fibrates - Niacin - Others incl PCSK9 inhibs, HDL elevs, HoFH Lipoprotein Correct Answer: transp form of lipids made up of lipids+prots since lipids insol in plasma Chylomicrons Correct Answer: lipoprot synth in intest made of dietary (exog) TGs+chol; most imp apoprot = ApoB-48 VLDL Correct Answer: lipoprot synth in liver made up of endog/hep TGs; most imp apoprot = ApoB-100 IDL Correct Answer: lipoprot synth from VLDL catab made up of chol esters+endog TGs; most imp apoprot = ApoB-100 LDL Correct Answer: lipoprot synth from VLDL catab expr in liver+intest, made up of chol esters; most imp apoprot = ApoB-100 HDL Correct Answer: lipoprot synt in intest, liver, plasma made up of phospholips+chol esters; most imp apoprot = ApoA LDL structure Correct Answer: core of chol esters + outer layer of ApoB-100, phospholipids, free chol mols Relationship of Lipoprotein Size & Density Correct Answer: largest lipoprot (chylomicrons) has lowest density; highest dens = Lp(a) & HDL Exogenous Pathway of Lipid Metabolism Correct Answer: 1). Diet TGs+chol incorp into large chylomic lipoprots 2). Chylomics hydr by LPL on endoth surf adip+musc, cleaving FAs from TGs 3). Chylomic enters circ as predom chol (chylomic remnant) 4). Chylomic remnant into liver by rec-med endocyt Endogenous Pathway of Lipid Metabolism Correct Answer: 1). Liver secr TGs+chol in VLDL form, metab by LPL -- IDL 2). Chol dens in IDL incr u
Escuela, estudio y materia
- Institución
- Kaplan University
- Grado
- B4 Pharm
Información del documento
- Subido en
- 7 de noviembre de 2022
- Número de páginas
- 31
- Escrito en
- 2022/2023
- Tipo
- Examen
- Contiene
- Preguntas y respuestas
Temas
-
b4 pharm exam 1 lectures 1 10
Documento también disponible en un lote